Fermenta Biotech informs about outcome of board meeting

12 Aug 2022 Evaluate
Fermenta Biotech has informed that the Board of Directors of the Company at its meeting held on August 12, 2022 has approved the unaudited financial results for the quarter ended June 30, 2022 (Standalone and Consolidated) as enclosed. It enclosed the Limited Review Report dated August 12, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. The Board meeting commenced at 11.15 am and concluded at 11.50 am.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

324.95 -1.05 (-0.32%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×